FUQA:LSE:LSE-Fidelity US Quality Income ETF Acc (GBX)

ETF | Others |

Last Closing

USD 955

Change

0.00 (0.00)%

Market Cap

N/A

Volume

718.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+1.10 (+0.53%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.30%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.10 (-0.52%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+4.93 (+3.62%)

USD 618.20B
0R1G:LSE Home Depot Inc.

+6.86 (+1.88%)

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.16 (-0.49%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.62 (-0.86%)

USD 266.08B
0QZO:LSE 0QZO

+1.31 (+1.17%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+4.60 (+3.19%)

USD 202.26B
0R24:LSE Intel Corp.

+0.52 (+2.61%)

USD 196.14B

ETFs Containing FUQA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.60% 19% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.60% 19% F 25% F
Trailing 12 Months  
Capital Gain 4.24% 44% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.24% 38% F 49% F
Trailing 5 Years  
Capital Gain 78.84% 74% C 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 78.84% 71% C- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 13.57% 73% C 76% C+
Dividend Return 13.57% 72% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.46% 73% C 85% B
Risk Adjusted Return 160.31% 99% N/A 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike